- Datum15.08.2025
- Uhrzeit17:00 - 18:00 Uhr
- Veranstalter
XTB
J. Klatt
Moderator
Kala Pharmaceuticals Aktie
Verkaufen
Kaufen
Kala Pharmaceuticals Chart
Echtzeit-News zu diesem und anderen Unternehmen findest Du hier!
Live-Ticker Kala Pharmaceuticals Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
0,25 %
Intraday
9,62 %
1 Woche
47,76 %
1 Monat
16,57 %
Seit Jahresbeginn
28,82 %
1 Jahr
-51,22 %
3 Jahre
-98,16 %
5 Jahre
Passender Service zu Kala Pharmaceuticals
Webinar zu Kala Pharmaceuticals
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)2,920-11,200
- Jahrestief / Hoch ($)2,920-11,200
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Kala Pharmaceuticals
Keine Dividenden verfügbar
Termine von Kala Pharmaceuticals
Keine aktuellen Termine
Beschreibung
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing innovative therapies for rare and severe eye diseases. KALA's lead product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
